<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of hemarthrosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of hemarthrosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of hemarthrosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter A Nigrovic, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Simon M Helfgott, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Siobhan M Case, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 26, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Bleeding into a joint is referred to as hemarthrosis and is an important cause of monoarticular joint pain and swelling. Hemarthrosis may be suspected on the basis of a suggestive history, physical examination, or imaging studies, but definitive diagnosis usually requires joint aspiration. The management is determined in part by the cause.</p><p>An overview of the causes, clinical manifestations, diagnosis, and management of hemarthrosis is reviewed here. The differential diagnosis of monoarthritis, techniques of joint aspiration (arthrocentesis), the approach to adults with a bleeding diathesis, and the diagnosis and management of hemophilia are described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1820.html" rel="external">"Monoarthritis in adults: Etiology and evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/7986.html" rel="external">"Joint aspiration or injection in adults: Technique and indications"</a> and  <a class="medical medical_review" href="/z/d/html/6425.html" rel="external">"Joint aspiration or injection in children: Indications, technique, and complications"</a> and  <a class="medical medical_review" href="/z/d/html/1367.html" rel="external">"Approach to the adult with a suspected bleeding disorder"</a> and  <a class="medical medical_review" href="/z/d/html/5936.html" rel="external">"Approach to the child with bleeding symptoms"</a> and  <a class="medical medical_review" href="/z/d/html/1310.html" rel="external">"Clinical manifestations and diagnosis of hemophilia"</a> and  <a class="medical medical_review" href="/z/d/html/1314.html" rel="external">"Treatment of bleeding and perioperative management in hemophilia A and B"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">CAUSES OF HEMARTHROSIS</span><span class="headingEndMark"> — </span>The range of disorders that may result in hemarthrosis can be broadly grouped into traumatic and nontraumatic causes; the latter include bleeding disorders, neurologic deficits, arthritis, neoplasms, vascular damage, and other miscellaneous causes  (<a class="graphic graphic_table graphicRef80811" href="/z/d/graphic/80811.html" rel="external">table 1</a>). (See <a class="local">'Traumatic'</a> below and <a class="local">'Nontraumatic'</a> below.)</p><p class="headingAnchor" id="H4"><span class="h2">Traumatic</span><span class="headingEndMark"> — </span>Injuries are among the most common causes of hemarthrosis. In patients with normal sensation and without a bleeding diathesis, joint trauma is generally remembered. The pain is often severe [<a href="#rid1">1</a>]. However, pain may be minimal or absent immediately following the event. Patients with impaired sensation from neuropathy or myelopathy may have little or no pain despite the presence of a fracture. (See <a class="local">'Knee injury'</a> below and <a class="local">'Lipohemarthrosis'</a> below and <a class="local">'Minimal injuries'</a> below and <a class="local">'Postoperative'</a> below.)</p><p>Following a major injury with intraarticular bleeding, synovial fluid rapidly accumulates within the joint. The accumulation of bloody fluid is due to soft tissue injury or to bone or osteochondral fracture. Serious ligamentous, osseous, or cartilage damage may be suspected when joint swelling occurs within 12 hours after trauma, although swelling is present much earlier, sometimes within two hours, in many patients [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H5"><span class="h3">Knee injury</span><span class="headingEndMark"> — </span>The knee is a frequent site of injury, and the majority of cases of posttraumatic hemarthrosis of the knee are associated with serious articular injury, often ligamentous and meniscal damage  (<a class="graphic graphic_table graphicRef65058" href="/z/d/graphic/65058.html" rel="external">table 2</a>). Thus, evaluation for internal derangement is an important part of the assessment (see  <a class="medical medical_review" href="/z/d/html/253.html" rel="external">"Approach to the adult with unspecified knee pain"</a>). The most common mechanism of injury in patients with acute hemarthrosis of the knee is forced twisting of the loaded joint [<a href="#rid2">2,3</a>].</p><p>Anterior cruciate ligament (ACL) tears are the most common cause, occurring in approximately 70 percent of patients with posttraumatic hemarthrosis of the knee [<a href="#rid2">2</a>]. Meniscal tears occur in 10 percent of patients, one-half of whom also have an ACL tear [<a href="#rid1">1</a>]. Patellar subluxation or dislocation occurs in 10 to 15 percent of patients, and osteochondral fracture fragments are found in 2 to 5 percent. Patellar subluxation may be a more common mechanism of hemarthrosis in children, accounting for 48 of 117 cases (41 percent) in one series [<a href="#rid4">4</a>]. Other lesions, such as posterior cruciate ligament injuries and capsule tears, occur in approximately 5 percent of patients.</p><p>Tenderness to palpation of the medial or lateral joint lines or the patella can indicate the site of injury [<a href="#rid1">1</a>]. Clinical tests for stability are performed with varus (for the lateral collateral ligament), valgus (for the medial collateral ligament), anterior (drawer test, for the ACL), and posterior (posterior draw or sag test, for the posterior cruciate ligament) stress  (<a class="graphic graphic_picture graphicRef89745 graphicRef73257" href="/z/d/graphic/89745.html" rel="external">picture 1A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/88813.html" rel="external">"Physical examination of the knee"</a> and  <a class="medical medical_review" href="/z/d/html/6514.html" rel="external">"Approach to acute knee pain and injury in children and skeletally immature adolescents", section on 'Evaluation'</a>.)</p><p>The initial imaging technique of choice is plain film radiography of the involved joint and adjacent bones. For the knee, we usually obtain anterior-posterior, lateral, patellar, and tunnel views [<a href="#rid5">5</a>]. When a fracture is strongly suspected but radiographs are negative, computed tomography (CT) may aid in diagnosis. Magnetic resonance imaging (MRI) provides helpful information about ligamentous and cartilaginous structures that are not typically visible with plain radiographs or CT.</p><p>Arthroscopic evaluation of the knee provides an alternative approach to assessing the severity of knee damage when injury is accompanied by hemarthrosis, but should generally be performed only if advanced imaging is not informative. In a prospective study, all injured knees that had a traumatic hemarthrosis with little or no instability on clinical examination underwent arthroscopy and examination under anesthesia [<a href="#rid6">6</a>]. One-third of the knees had slight or no pain at the time of the injury. Some degree of disruption of the ACL of the involved knee was found in 71 percent of the patients examined, while a torn meniscus was present in 47 percent. A meniscal tear was frequently associated with injuries of varying severity to other joint structures. Other damage found during arthroscopy and examination under anesthesia included minor ligament sprains without laxity, major associated ligament injury, and femoral cartilage fractures or surface defects [<a href="#rid6">6</a>]. When examined without anesthesia, some patients with documented ACL tears did not have a positive drawer sign.</p><p class="headingAnchor" id="H6"><span class="h3">Lipohemarthrosis</span><span class="headingEndMark"> — </span>Lipohemarthrosis, which is the presence of fat and blood in a joint cavity, is usually caused by intracapsular fractures or extensive intraarticular soft tissue injury [<a href="#rid2">2</a>]. Lipohemarthrosis can be detected by arthrocentesis, by CT scan or MRI, and/or plain radiology  (<a class="graphic graphic_diagnosticimage graphicRef88737" href="/z/d/graphic/88737.html" rel="external">image 1</a>) [<a href="#rid2">2,7</a>]. While a single fluid-fluid level on cross-table plain radiographs is suggestive of lipohemarthrosis, this finding may also occur due to separation of intraarticular cellular and fluid components following intraarticular bleeding without the presence of fat in joint fluid [<a href="#rid8">8</a>]. The finding of a double fluid-fluid level is more specific for lipohemarthrosis [<a href="#rid7">7</a>]. The diagnosis can be suggested also by ultrasonography [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H7"><span class="h3">Minimal injuries</span><span class="headingEndMark"> — </span>In patients in whom hemarthrosis occurs after minimal trauma, coagulation disorders, such as hemophilia, an acquired inhibitor to factor VIII, or other disorder of blood clotting should be suspected [<a href="#rid10">10</a>] (see  <a class="medical medical_review" href="/z/d/html/1367.html" rel="external">"Approach to the adult with a suspected bleeding disorder"</a>). When hemarthrosis following minimal trauma is not due to a bleeding diathesis, the most commonly documented injuries are ACL and meniscal tears [<a href="#rid8">8,11</a>].</p><p class="headingAnchor" id="H8"><span class="h3">Postoperative</span><span class="headingEndMark"> — </span>Recurrent postoperative hemarthrosis is an uncommon complication of total knee arthroplasty, seen in approximately 1 percent of such patients, and is most often due to impingement of hypertrophic synovium by the prosthesis [<a href="#rid12">12</a>]. It may present at any point within the first year after surgery, and can be addressed by operative excision of the affected tissue or by embolization of feeding vessels. Hemarthrosis is also a potential but unusual complication after performing lateral releases or after arthroscopy [<a href="#rid13">13-16</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Nontraumatic</span><span class="headingEndMark"> — </span>A variety of hereditary, acquired, and iatrogenic bleeding disorders can result in hemarthrosis. Other potential causes are neurologic, infectious, and vascular diseases, arthritis, particularly osteoarthritis with associated chondrocalcinosis, and neoplasms. (See <a class="local">'Bleeding disorders'</a> below and <a class="local">'Osteoarthritis'</a> below and <a class="local">'Neurologic disorders'</a> below and <a class="local">'Septic arthritis'</a> below and <a class="local">'Vascular disorders'</a> below and <a class="local">'Tumors'</a> below.)</p><p class="headingAnchor" id="H10"><span class="h3">Bleeding disorders</span><span class="headingEndMark"> — </span>Bleeding disorders should be considered as the underlying cause when hemarthrosis occurs with minimal or no trauma. Questions about bleeding during or after surgical or dental procedures, use of anticoagulant medications [<a href="#rid17">17,18</a>], and rarely, thrombolysis [<a href="#rid19">19,20</a>] or extreme dietary restriction (vitamin C deficiency) may help uncover the presence of a bleeding diathesis or its cause.</p><p>Initial laboratory tests include a complete blood count, prothrombin time (PT), and activated partial thromboplastin time (aPTT)  (<a class="graphic graphic_table graphicRef79969" href="/z/d/graphic/79969.html" rel="external">table 3</a>). A bleeding time may be helpful if the history or physical examination suggests a platelet disorder; however, joint bleeding is typically seen with deficiencies in coagulation factors, rather than platelet abnormality  (<a class="graphic graphic_table graphicRef77834" href="/z/d/graphic/77834.html" rel="external">table 4</a>). Unexplained abnormalities of any of these tests require further investigation, which is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1367.html" rel="external">"Approach to the adult with a suspected bleeding disorder"</a>.)</p><p>Hemarthrosis is the most common musculoskeletal manifestation of hemophilia [<a href="#rid21">21</a>]. Severe hemophilia (defined as less than 1 percent of normal factor activity) causes hemarthrosis in 75 to 90 percent of patients. The first attack usually occurs between two or three years of age. The knee is the most common joint involved, followed by the elbow, ankle, hip, and shoulder. Bleeding commonly recurs in a subset of joints, referred to as "target joints," that are at highest risk for permanent injury. Bilateral involvement is not uncommon [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/z/d/html/1310.html" rel="external">"Clinical manifestations and diagnosis of hemophilia", section on 'Hemophilic arthropathy'</a>.)</p><p>Three forms of hemarthrosis are recognized in patients with hemophilia: acute, subacute, and chronic.</p><p class="bulletIndent1"><span class="glyph">●</span>In acute hemarthrosis, the affected joint is painful, swollen, and warm, and range of motion is reduced. The clinical manifestations vary by age. In infants, early signs of bleeding include irritability and decreased use of the affected limb. In older children and adults, hemarthrosis is manifested by prodromal stiffness and, in some patients, by a characteristic "aura" (often a sensation of tingling or warmth), which is followed by acute pain and swelling [<a href="#rid22">22</a>]. One joint is usually affected at a time, but multiple bleeding sites are not uncommon. Symptoms respond rapidly to plasma and factor replacement, and as the effusion is reabsorbed, mobility returns.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Untreated hemorrhage can lead to intraarticular damage in the subacute stage. In this stage, the toxic effects of blood products lead to synovial hypertrophy, fibrosis, and impaired joint movement. Despite marked internal derangement, joint pain is not prominent at this time.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Repeated attacks or persistent hemorrhage for more than six months can lead to chronic disabling arthropathy, with symptoms sometimes mimicking osteoarthritis. Chronic arthropathy can affect 20 percent or more of patients with hemophilia [<a href="#rid23">23</a>].</p><p></p><p>The histopathology of hemophilic arthropathy is complex [<a href="#rid24">24,25</a>]. In early disease, the histology reveals synovial hypertrophy and fibrosis, changes similar to rheumatoid arthritis. Late disease is characterized by disruption of cartilage and by subchondral bone cyst formation. Cyst formation appears to reflect the combined effects of degeneration and interosseous bleeding [<a href="#rid26">26-28</a>]. Cartilage and bone destruction in affected patients appears to be the result of direct toxic effects of blood products, mechanical effects, and cytokines [<a href="#rid26">26</a>]. Iron, in the form of <a class="drug drug_general" data-topicid="96959" href="/z/d/drug information/96959.html" rel="external">ferric citrate</a>, stimulates human synovial fibroblasts to proliferate in vitro [<a href="#rid29">29</a>]. In vitro data suggest that blood can be toxic to human cartilage after as little as two days, a conclusion supported by studies of induced hemarthrosis in hemophilic rats [<a href="#rid30">30,31</a>]. Interestingly, susceptibility to joint injury may reflect in part the impaired wound healing observed in hemophilia, since wild-type animals subjected to experimental hemarthrosis exhibited more rapid clearance of joint bleeding than mice with inherited coagulation defects and were correspondingly protected from associated structural injury [<a href="#rid32">32</a>]. Murine studies suggest that blood vessel hyperplasia occurs in reaction to hemarthrosis, potentially predisposing to recurrent bleeding in a subset of joints characteristic of each patient ("target joints," defined as joints affected by at least three bleeding episodes within six months) [<a href="#rid22">22,33</a>]. Growing cartilage is most susceptible to blood-induced damage [<a href="#rid34">34</a>]. Thus, children with hemarthrosis should be treated aggressively to minimize joint injury.</p><p>Radiologically, five stages of hemophilic arthropathy are recognized [<a href="#rid21">21</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 1: Soft tissue swelling – Swelling secondary to direct bleeding, both into the joint and into the adjacent tissues.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage 2: Osteoporosis – Development of osteoporosis and/or epithelial overgrowth associated with inflammatory hyperemia, especially marked in the knee and elbow.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage 3: Osseous lesions – Disorganization of the joint with overgrowth of the epiphysis, squaring of the patella, and widening of the articular notch of the knee and the trochlea of the ulna; the articular cartilage remains intact.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage 4: Cartilage destruction – Cartilage injury and secondary joint space narrowing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage 5: Joint disorganization – Complete loss of cartilage spaces with associated bony erosion and irregularity.</p><p></p><p>Radiographic assessment of hemophilic arthropathy tends to underestimate the joint destruction. MRI and CT allow for early evaluation of joint damage, subchondral cysts, and cartilage or synovial lesions.</p><p>Treatment of hemarthrosis in the setting of hemophilia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1314.html" rel="external">"Treatment of bleeding and perioperative management in hemophilia A and B", section on 'Hemarthroses'</a>.)</p><p class="headingAnchor" id="H11"><span class="h3">Osteoarthritis</span><span class="headingEndMark"> — </span>Hemarthrosis of the knee can occur as a result of osteoarthritis; however, this is uncommon as osteoarthritis usually only causes a small amount of bleeding, and should be regarded as a diagnosis of exclusion. The origin of bleeding in several reported cases was presumed to be from the peripheral arteries of the posterior horn of the lateral meniscus, which were found to have degenerative tears [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H12"><span class="h3">Neurologic disorders</span><span class="headingEndMark"> — </span>Recurrent episodes of hemarthrosis can occur in patients with neuropathic arthropathy (Charcot joints). Note that Charcot joints are often still somewhat painful. (See  <a class="medical medical_review" href="/z/d/html/5608.html" rel="external">"Diabetic neuroarthropathy"</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Septic arthritis</span><span class="headingEndMark"> — </span>Hemarthrosis may occur without associated trauma in patients with bacterial arthritis, though this is rare [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/z/d/html/7666.html" rel="external">"Septic arthritis in adults"</a>.)</p><p class="headingAnchor" id="H14"><span class="h3">Vascular disorders</span><span class="headingEndMark"> — </span>Vascular fragility due to vitamin C deficiency may lead to hemarthrosis and subperiosteal bleeding [<a href="#rid37">37</a>] (see  <a class="medical medical_review" href="/z/d/html/5367.html" rel="external">"Overview of water-soluble vitamins", section on 'Vitamin C (ascorbic acid)'</a>). Peripheral arterial aneurysms or, more commonly, procedure-related pseudoaneurysms may rupture, resulting in intraarticular hemorrhage [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H15"><span class="h3">Tumors</span><span class="headingEndMark"> — </span>The neoplasms most often associated with hemarthrosis are generally benign. Two important types are synovial hemangiomas (see <a class="local">'Synovial hemangioma'</a> below) and tenosynovial giant cell tumor (TCGT), historically known as pigmented villonodular synovitis (PVNS) (see <a class="local">'Tenosynovial giant cell tumor/pigmented villonodular synovitis'</a> below). Malignant tumors, both metastatic and those arising de novo in or near a joint, can lead to bloody effusions.</p><p class="headingAnchor" id="H1435166137"><span class="h4">Synovial hemangioma</span><span class="headingEndMark"> — </span>A synovial hemangioma is a rare benign vascular tumor that can occur in a joint, usually the knee. Children are more likely to have intraarticular hemangiomas than adults. Affected patients present with a recurrent painful monoarticular hemarthrosis [<a href="#rid39">39</a>].</p><p>Plain film radiography is normal in half of the patients or shows joint effusion, soft tissue swelling, and/or erosions. The presence of phleboliths is suggestive of hemangioma, but MRI is the modality of choice for diagnosis [<a href="#rid40">40,41</a>].</p><p>Synovial hemangiomas may be congenital, appearing as solitary neoplasms that infiltrate local tissue and adjacent neurologic structures. The margins of the mass are typically composed of both large and small vessels. Hemangiomas do not metastasize or undergo malignant transformation. Pathologic examination of hemangiomas shows spaces of various sizes, ranging from capillaries to cavernous sinusoids, which are lined by endothelium.</p><p class="headingAnchor" id="H2392762357"><span class="h4">Tenosynovial giant cell tumor/pigmented villonodular synovitis</span><span class="headingEndMark"> — </span>Tenosynovial giant cell tumor (TGCT), historically known as pigmented villonodular synovitis (PVNS), is a slow-growing, benign, but locally invasive tumor of the synovium. It most commonly involves the knee, but can also occur in the hip, ankle, and elbow. Episodic acute attacks of pain and swelling are associated with spontaneous hemarthrosis, but hemarthrosis may also be identified unexpectedly upon joint aspiration performed as part of the evaluation of a chronically swollen joint.</p><p>Most patients with knee involvement have difficulty in ambulation, and may experience locking and catching of the joint. This tumor-like growth may be driven by overexpression of colony stimulating factor 1 (CSF1, also known as macrophage-CSF [M-CSF]) by a minority of cells, driving recruitment and expansion of CSF1-responsive neighboring cells [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/7733.html" rel="external">"Treatment for tenosynovial giant cell tumor and other benign neoplasms affecting soft tissue and bone", section on 'Tenosynovial giant cell tumor'</a>.)</p><p>The synovial fluid classically is dark brown or hemorrhagic. A synovial biopsy may be diagnostic. The histopathology of TGCT can mimic rheumatoid arthritis, but TGCT affects few joints and rarely in a symmetrical fashion. It usually presents as a monoarticular hemarthrosis and it may exist in a diffuse or nodular form [<a href="#rid43">43</a>].</p><p>The diffuse form is characterized by a history of swelling that is not preceded by trauma. On physical examination, the majority of patients have distension of the suprapatellar pouch and a large effusion. As many as 40 percent may have a palpable diffuse synovial mass. This can be accompanied by periarticular erosions on plain radiographs.</p><p>The nodular form is less common and does not show the same destructive changes as the diffuse form. It can cause recurrent hemarthrosis, but the aspirate may be of normal color and not show the classic changes or radiographic findings.</p><p>The most common feature of TGCT on MRI is the presence of intraarticular nodules or masses. MRI findings are very useful in the diagnosis of TGCT, because hemosiderin in the tissues renders TGCT "dark" on all MRI sequences due to a characteristic lack of signal on both T1 and T2 images.</p><p>The treatment of TGCT is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/7733.html" rel="external">"Treatment for tenosynovial giant cell tumor and other benign neoplasms affecting soft tissue and bone", section on 'Tenosynovial giant cell tumor'</a>.)</p><p class="headingAnchor" id="H160556864"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H177856081"><span class="h2">Symptoms and physical findings</span><span class="headingEndMark"> — </span>The presentation of hemarthrosis varies with the etiology and is particularly influenced by the acuity or chronicity of bleeding (see <a class="local">'Causes of hemarthrosis'</a> above). Pain, stiffness, reduced range of motion, swelling, and warmth are typically present but can range from very mild to severe.</p><p>As an example, acute intraarticular bleeding, as occurs with trauma or from an acute hemophilic bleed, typically occurs immediately and is often intensely painful. However, subacute bleeding that occurs with articular tumors such as tenosynovial giant cell tumor (TGCT) may be identified as an unexpected finding upon joint aspiration performed as part of the diagnostic evaluation of a swollen joint. In such cases, joint swelling, stiffness, and mild to moderate discomfort may be the only presenting symptoms. (See <a class="local">'Traumatic'</a> above and <a class="local">'Bleeding disorders'</a> above and <a class="local">'Tenosynovial giant cell tumor/pigmented villonodular synovitis'</a> above.)</p><p>Patients with hemophilia may report a vague sensation of tingling or warmth at the onset of acute bleeding, termed an aura, followed by tightness and reduced motion, which is typically accompanied by increasing pain, warmth, and acute swelling. Knees are most commonly affected in this group, but elbows and ankles are commonly affected as well. (See <a class="local">'Bleeding disorders'</a> above.)</p><p class="headingAnchor" id="H1210073285"><span class="h2">Synovial fluid analysis and other laboratory findings</span><span class="headingEndMark"> — </span>Synovial fluid obtained from a patient with hemarthrosis may appear red, pink, or brown. Other abnormalities of the fluid may be noted that depend upon the cause of bleeding. As an example, the presence of lipid globules strongly suggests an intraarticular fracture, resulting in leakage of marrow fat into the synovial fluid (see <a class="local">'Lipohemarthrosis'</a> above). A true bloody effusion usually fails to clot due to chronic fibrinolysis, while blood from a traumatic aspiration generally does coagulate [<a href="#rid36">36</a>].</p><p>Following centrifugation of joint fluid, the aspirate from a patient with hemarthrosis will generally exhibit xanthochromia from lysis of the resident erythrocytes. This characteristic can help to distinguish a bloody or blood-tinged fluid due to a traumatic arthrocentesis from true hemarthrosis. (See <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/z/d/html/1828.html" rel="external">"Synovial fluid analysis"</a>.)</p><p>Laboratory findings on testing of peripheral blood depend upon the presence of comorbid conditions, but otherwise hemarthrosis alone does not cause changes in general laboratory testing.</p><p class="headingAnchor" id="H2907475264"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>Standard plain radiography often suggests soft tissue swelling and joint effusion; in patients with chronic, recurrent hemarthrosis (eg, in hemophilia) additional changes may occur over time, including in cartilage and bone (see <a class="local">'Bleeding disorders'</a> above and  <a class="medical medical_review" href="/z/d/html/1310.html" rel="external">"Clinical manifestations and diagnosis of hemophilia", section on 'Hemophilic arthropathy'</a>). Rarely, patients with large effusions may exhibit a blood-fluid level that is evident on radiography.</p><p>Computed tomography (CT) is most sensitive to the detection of acute blood but does not provide soft tissue or cartilage information. Hemosiderin is easily identified as low signal intensity on joint magnetic resonance imaging (MRI). Echogenic intraarticular fluid seen on ultrasound also indicates articular hemorrhage.</p><p>Imaging, especially MRI, may provide clues to other etiologies for hemarthrosis including fracture, intraarticular vascular malformation, and tenosynovial giant cell tumor (pigmented villonodular synovitis).</p><p class="headingAnchor" id="H160556875"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of hemarthrosis is usually made by joint aspiration, which typically reveals joint fluid that is overtly and uniformly sanguineous, although with chronicity, the fluid can become rusty or brown in color. Centrifugation discloses xanthochromia (yellow-tinged discoloration) of the supernatant, from ruptured red blood cells, distinguishing hemarthrosis from bleeding due to trauma incurred during the procedure itself. By contrast, in a traumatic tap, the fluid will typically change color from less to more sanguineous over the course of the procedure, while the supernatant of a centrifuged sample will disclose typical straw-colored fluid.</p><p>Arthrocentesis is generally not required for diagnosis when the underlying cause is already known with confidence (eg, patients with hemophilia and a history of hemarthrosis, or patients with acute trauma and known intraarticular injury), and when important alternate diagnoses such as septic arthritis can be excluded clinically.</p><p>Aspiration of larger effusions should be performed using a needle of sufficient gauge (eg, 18-gauge) to permit evacuation to relieve capsular distension and pain. If there is diagnostic uncertainty, fluid should be sent for cytology to evaluate potential malignancy in addition to routine synovial fluid studies (cell count, differential, Gram stain, culture, and, if indicated, crystal analysis).</p><p>In patients with plain radiographic evidence of trauma, the diagnosis of hemarthrosis is further supported by the appearance of a blood-fluid level in larger effusions, which is occasionally present.</p><p class="headingAnchor" id="H160556598"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>A wide variety of infectious and inflammatory conditions may cause an acute monoarthritis and could clinically mimic hemarthrosis. The history and physical examination frequently help to suggest the presence of a cause of likely hemarthrosis, such as trauma or hemophilia, or another articular disorder. The finding of hemorrhagic joint fluid on synovial fluid analysis is the key finding that distinguishes hemarthrosis from other disorders causing similar symptoms and physical findings. The differential diagnosis of acute monoarticular joint pain and swelling is reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1820.html" rel="external">"Monoarthritis in adults: Etiology and evaluation"</a>.)</p><p>The principal mimickers of hemarthrosis include traumatic arthrocentesis, resulting in bloody "contamination" of synovial fluid; many conditions that may cause arthritis that can present with acute joint pain and swelling; and chronic hemophilic arthritis, which can present in a clinical setting typically associated with acute hemarthrosis. The major conditions of importance in the differential diagnosis include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Traumatic arthrocentesis</strong> – A traumatic arthrocentesis is the most likely cause of a bloody synovial fluid sample when the aspiration is not initially bloody, but fresh blood appears after some synovial fluid has been withdrawn. In this case, centrifugation of the specimen to examine the appearance of the resultant supernatant is useful. A serous appearance of the synovial fluid supernatant suggests that fresh blood has been mixed with previously nonbloody fluid. A true bloody effusion usually fails to clot due to chronic fibrinolysis, while blood from a traumatic aspiration generally does coagulate. The aspirate from a patient with hemarthrosis will generally exhibit xanthochromia from lysis of the resident erythrocytes. (See <a class="local">'Synovial fluid analysis and other laboratory findings'</a> above and  <a class="medical medical_review" href="/z/d/html/1828.html" rel="external">"Synovial fluid analysis", section on 'Categories of joint effusions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute monoarthritis</strong> – A number of medical conditions may present with similar clinical symptoms to hemarthrosis, but the major differentiating factor is nonhemorrhagic joint effusions, in addition to the history and physical examination findings that typify other disorders. Major conditions that may also cause acute pain and joint swelling, similar to hemarthrosis, can be excluded by history and synovial fluid analysis. These conditions include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bacterial septic arthritis</strong> – Bacterial septic arthritis typically presents with concomitant fever, and the diagnosis of septic arthritis can be confirmed with synovial fluid analysis and culture (see <a class="local">'Septic arthritis'</a> above and  <a class="medical medical_review" href="/z/d/html/7666.html" rel="external">"Septic arthritis in adults"</a>). In hemarthrosis, body temperature is often not elevated, there are minimal white blood cells in the synovial fluid, and the culture should be negative.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Crystal arthropathy</strong> – The diagnosis of a crystal arthropathy (gout or calcium pyrophosphate deposition disease) is often suggested by the medical history and made by the identification of crystals on synovial fluid analysis. Occasionally, calcium pyrophosphate crystal deposition (CPPD) disease can present as "pseudo-hemarthrosis," with recurrent bleeding particularly affecting the shoulder, especially in the context of concomitant osteoarthritis [<a href="#rid44">44</a>]. (See  <a class="medical medical_review" href="/z/d/html/1667.html" rel="external">"Clinical manifestations and diagnosis of gout"</a> and  <a class="medical medical_review" href="/z/d/html/1668.html" rel="external">"Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition (CPPD) disease"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Reactive arthritis</strong> – Reactive arthritis can generally be distinguished by the characteristic history of antecedent infection and differentiated from hemarthrosis by synovial fluid analysis. (See  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lyme arthritis</strong> – Lyme arthritis may be characterized, like hemarthrosis, by large joint mono- or oligoarthritis, especially of the knee, but occurs in an endemic region and may have other typical historical and physical features such as a prior tick bite and typical rash; the diagnosis of Lyme disease can generally be confirmed (or excluded) by serologic testing. (See  <a class="medical medical_review" href="/z/d/html/7894.html" rel="external">"Musculoskeletal manifestations of Lyme disease"</a> and  <a class="medical medical_review" href="/z/d/html/7914.html" rel="external">"Diagnosis of Lyme disease"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Primary inflammatory arthropathies</strong> – Primary inflammatory arthropathies (which may also present with a mono- or oligoarthritis), such as rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritis, can mimic hemarthrosis when only one or a few joints are involved, but can be distinguished by medical history, examination, and synovial fluid analysis. (See  <a class="medical medical_review" href="/z/d/html/7504.html" rel="external">"Diagnosis and differential diagnosis of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/z/d/html/6415.html" rel="external">"Oligoarticular juvenile idiopathic arthritis"</a> and  <a class="medical medical_review" href="/z/d/html/6414.html" rel="external">"Polyarticular juvenile idiopathic arthritis: Clinical manifestations, diagnosis, and complications"</a> and  <a class="medical medical_review" href="/z/d/html/6413.html" rel="external">"Systemic juvenile idiopathic arthritis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">"Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">"Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic hemophilic arthropathy</strong> – In patients with hemophilia and recurrent intraarticular bleeding, it may be difficult to distinguish new hemarthrosis from exacerbations of pain from underlying chronic joint injury. In both cases, patients present with pain, limited motion, swelling, stiffness, and joint warmth, although an acute painful episode combined with overt joint fullness (ie, substantial effusion) and a patient report of new tenseness in the joint should suggest hemarthrosis [<a href="#rid45">45</a>]. In some cases, patients with hemarthrosis report an aura (tingling or warmth) in the joint prior to new swelling and pain, providing another potentially helpful clue [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/z/d/html/1310.html" rel="external">"Clinical manifestations and diagnosis of hemophilia", section on 'Hemophilic arthropathy'</a>.)</p><p></p><p class="headingAnchor" id="H160556897"><span class="h1">POSTDIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>Once the diagnosis of hemarthrosis has been established, the further management depends in part upon the cause; for example, orthopedic management should be undertaken for acute injuries or factor replacement should be administered in hemophiliacs. Thus, in patients in whom no cause is immediately evident on history, examination, and synovial fluid analysis, additional studies, such as further history, laboratory testing, imaging, and/or cytology, may be required to evaluate the possibility of a more subtle intraarticular lesion, intraarticular neoplasm, or other disorder.</p><p>In patients with bleeding that occurs with minor or no trauma, evaluation for coagulopathy should be undertaken if that diagnosis has not been previously established. Patients suspected of a coagulopathy should be referred to a hematologist with expertise in coagulation disorders.</p><p class="headingAnchor" id="H16"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of hemarthrosis can be divided into interventions that are generally useful for any patient with acute hemarthrosis, and more specific treatments directed toward the underlying disorder. (See <a class="local">'General approach'</a> below and <a class="local">'Cause-specific interventions'</a> below.)</p><p class="headingAnchor" id="H17"><span class="h2">General approach</span><span class="headingEndMark"> — </span>The goals of initial treatment are to limit further joint injury and optimize patient comfort. We advise the following approach, based upon case series and expert opinion [<a href="#rid46">46-48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial/acute therapy</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with acute posttraumatic hemarthrosis should be treated initially by immobilization of the affected joint, application of ice, and compression.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with a tense effusion and those in whom the diagnosis is uncertain, aspiration of the joint may help provide pain relief.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Potent analgesics may be required while the diagnostic evaluation proceeds, but most nonselective nonsteroidal antiinflammatory drugs, other than cyclooxygenase (COX) 2 selective agents that don't affect platelet function, should be avoided in the first 48 to 72 hours because of the increased risk of bleeding associated with their use. The decision regarding whether to use opioid analgesics in patients unresponsive to nonopioid agents, and the type of agent in patients receiving such therapy, should be made on an individualized basis taking the patient's history of analgesic use into account.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postacute phase interventions</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nonsteroidal antiinflammatory drugs (NSAIDs) may be employed when the acute hemorrhage risk has receded, 48 to 72 hours after the injury, unless coagulopathy evaluation or immediate surgical intervention is planned. The presence of a coagulopathy influences drug choices. (See <a class="local">'Coagulation disorders/hemophilia'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Depending upon the rate and extent of the clinical response to initial measures, some patients may require immobilization, the application of ice, and compression for up to a week.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Joint lavage is generally not indicated, other than potentially in patients with hemophilia with recurrent hemarthrosis (see <a class="local">'Coagulation disorders/hemophilia'</a> below), because an isolated episode of bleeding into the joint is unlikely to cause lasting injury.</p><p></p><p class="headingAnchor" id="H18"><span class="h2">Cause-specific interventions</span><span class="headingEndMark"> — </span>In patients in whom a definite cause for the hemarthrosis can be identified, interventions specific to the particular etiology can be employed. (See <a class="local">'After major trauma'</a> below and <a class="local">'Coagulation disorders/hemophilia'</a> below and <a class="local">'Patients receiving anticoagulation'</a> below and <a class="local">'Postoperative'</a> below and <a class="local">'Vascular causes'</a> below and <a class="local">'Benign tumors'</a> below.)</p><p class="headingAnchor" id="H19"><span class="h3">After major trauma</span><span class="headingEndMark"> — </span>Patients with major trauma and hemarthrosis should be evaluated and managed in collaboration with an orthopedic surgeon; such patients are at risk for significant bone and soft tissue injuries. (See <a class="local">'Traumatic'</a> above and <a class="local">'Knee injury'</a> above.)</p><p>The involved joint should be completely immobilized until radiographs have been obtained; in patients with evidence of a fracture or suspicion of an internal derangement, orthopedic consultation should be obtained. Although not all intraarticular fractures require operative intervention, the patient and radiographic findings should be reviewed with a clinician experienced in fracture care. Ligamentous and meniscal injuries generally do not require immediate operative intervention.</p><p class="headingAnchor" id="H20"><span class="h3">Coagulation disorders/hemophilia</span><span class="headingEndMark"> — </span>The prevention and treatment of acute and chronic hemarthrosis in patients with known clotting factor deficiency is described in detail separately. (See <a class="local">'Bleeding disorders'</a> above and  <a class="medical medical_review" href="/z/d/html/7969.html" rel="external">"Synovectomy for inflammatory arthritis of the knee"</a> and  <a class="medical medical_review" href="/z/d/html/1314.html" rel="external">"Treatment of bleeding and perioperative management in hemophilia A and B", section on 'Hemarthroses'</a> and  <a class="medical medical_review" href="/z/d/html/110258.html" rel="external">"Chronic complications and age-related comorbidities in people with hemophilia", section on 'Arthropathy'</a> and  <a class="medical medical_review" href="/z/d/html/107911.html" rel="external">"Hemophilia A and B: Routine management including prophylaxis", section on 'Prophylaxis versus on-demand therapy'</a>.)</p><p>In hemophilic patients with recurrent hemarthrosis, the role of lavage to avoid the long-term consequences of recurrent hemarthrosis is uncertain, although observational but uncontrolled data suggest good outcomes with prompt arthrocentesis, <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> lavage, and glucocorticoid instillation [<a href="#rid49">49</a>].</p><p>Use of the selective cyclooxygenase (COX) 2 inhibitors <a class="drug drug_general" data-topicid="8847" href="/z/d/drug information/8847.html" rel="external">celecoxib</a> and etoricoxib is safe and effective in patients with hemophilic arthropathy [<a href="#rid50">50,51</a>]. Since the selective COX-2 inhibitors do not interfere with platelet function and may be less likely to cause gastroduodenal damage than nonselective NSAIDs, this approach may be useful for treating chronic joint pain in those with clotting factor deficiencies who require an NSAID [<a href="#rid48">48,52</a>]. The use and safety of celecoxib are described separately. (See  <a class="medical medical_review" href="/z/d/html/7992.html" rel="external">"Overview of COX-2 selective NSAIDs"</a> and  <a class="medical medical_review" href="/z/d/html/7968.html" rel="external">"NSAIDs: Adverse cardiovascular effects", section on 'Aspirin and other antithrombotic agents'</a>.)</p><p>One small series reported reduction of both recurrent hemarthrosis and synovitis in three hemophilia patients treated with tumor necrosis factor (TNF) inhibitors for concurrent inflammatory arthritis, providing anecdotal support for this approach [<a href="#rid53">53</a>]. Further support comes from murine studies that have implicated TNF as a mediator of hemophilia-associated joint inflammation and injury [<a href="#rid54">54,55</a>].</p><p class="headingAnchor" id="H95764583"><span class="h3">Patients receiving anticoagulation</span><span class="headingEndMark"> — </span>Clinically important hemarthrosis in patients receiving therapeutic anticoagulation is rare. Diagnostic or therapeutic arthrocentesis is usually well tolerated in these patients despite the use of such therapies [<a href="#rid56">56</a>]. In most patients, temporary immobilization and analgesics will be the only treatment necessary after correction, if needed, of excessive anticoagulation. In the unusual event of persistent or recurrent hemarthrosis, an anatomic cause should be sought [<a href="#rid57">57</a>]. If the patient is not at immediate risk of thromboembolism, reversal of anticoagulation may be appropriate, provided that the benefits outweigh the risks of thromboembolism. (See  <a class="medical medical_review" href="/z/d/html/1324.html" rel="external">"Management of warfarin-associated bleeding or supratherapeutic INR"</a> and  <a class="medical medical_review" href="/z/d/html/7986.html" rel="external">"Joint aspiration or injection in adults: Technique and indications", section on 'Approach to the patient on anticoagulants'</a> and  <a class="medical medical_review" href="/z/d/html/94788.html" rel="external">"Management of bleeding in patients receiving direct oral anticoagulants"</a>.)</p><p class="headingAnchor" id="H21"><span class="h3">Postoperative</span><span class="headingEndMark"> — </span>Patients with recurrent postoperative hemarthrosis may require revision surgery and should be referred to their orthopedic surgeon for further evaluation and management (see <a class="local">'Postoperative'</a> above). In one reported case, angiographically guided embolization controlled recurrent bleeding into the knee in a patient who required chronic anticoagulation [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H22"><span class="h3">Vascular causes</span><span class="headingEndMark"> — </span>In patients with an aneurysm or pseudoaneurysm as the cause of intraarticular bleeding, surgical intervention is often required. In patients in whom surgical treatment is not feasible, endovascular treatment with arterial embolization may be an option [<a href="#rid38">38,59</a>]. (See <a class="local">'Vascular disorders'</a> above.)</p><p class="headingAnchor" id="H23"><span class="h3">Benign tumors</span><span class="headingEndMark"> — </span>In patients with benign tumors that lead to hemarthrosis, arthroscopic or surgical synovectomy is usually the treatment of choice to prevent recurrent episodes of hemarthrosis. (See <a class="local">'Tumors'</a> above and  <a class="medical medical_review" href="/z/d/html/7969.html" rel="external">"Synovectomy for inflammatory arthritis of the knee"</a>.)</p><p class="headingAnchor" id="H160556818"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The prognosis of hemarthrosis varies with the specific cause. For trauma and tumors, the prognosis is typically that of the inciting process. Repeated intraarticular hemorrhage in hemophilia carries a high risk of chronic hemophilic arthropathy, experienced by 20 percent or more of patients even in the era of factor replacement [<a href="#rid60">60-62</a>]. (See  <a class="medical medical_review" href="/z/d/html/1310.html" rel="external">"Clinical manifestations and diagnosis of hemophilia", section on 'Hemophilic arthropathy'</a>.)</p><p class="headingAnchor" id="H2915034194"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112393.html" rel="external">"Society guideline links: Hemophilia A and B"</a>.)</p><p class="headingAnchor" id="H167399909"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Hemarthrosis, or bleeding into a joint, can occur from a variety of causes  (<a class="graphic graphic_table graphicRef80811" href="/z/d/graphic/80811.html" rel="external">table 1</a>) and results in monoarticular pain and swelling. Diagnosis usually requires joint aspiration, which reveals red, pink, or brown synovial fluid; arthrocentesis is needed whenever septic arthritis is suspected. Arthrocentesis is generally not required for diagnosis when the underlying cause is known with confidence (eg, patients with hemophilia and a history of hemarthrosis, acute trauma), and when important alternate diagnoses such as septic arthritis can be excluded clinically. Other abnormalities of the fluid depend upon the cause of the bleeding. (See <a class="local">'Causes of hemarthrosis'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A true bloody effusion usually fails to clot due to chronic fibrinolysis, while blood from a traumatic aspiration generally does coagulate. Traumatic arthrocentesis is most likely if the aspiration is not bloody initially, but fresh blood appears after some synovial fluid has been withdrawn. (See <a class="local">'Causes of hemarthrosis'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Injuries are among the most common causes of hemarthrosis. The pain is often severe but may be minimal or absent immediately following the event. Patients with impaired sensation from neuropathy or myelopathy may have little or no pain despite the presence of a fracture. The rapid accumulation of bloody fluid that follows a major injury with intraarticular bleeding is due to soft tissue injury or bone/osteochondral fracture. (See <a class="local">'Traumatic'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The knee is a frequent site of injury, and evaluation for internal derangement is an important part of the evaluation. The most common mechanism of injury in patients with acute hemarthrosis of the knee is forced twisting of the loaded joint. The initial imaging technique of choice is plain film radiography. If a fracture is strongly suspected but radiographs are negative, computed tomography (CT) may aid in diagnosis; however, magnetic resonance imaging (MRI) also provides helpful information about ligamentous and cartilaginous structures. Arthroscopic evaluation of the knee may be helpful in some patients. (See <a class="local">'Knee injury'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Additional concerns in patients with traumatic hemarthrosis include lipohemarthrosis, recurrent postoperative hemarthrosis following total knee arthroplasty, and coagulation disorders, which should be suspected in patients in whom hemarthrosis occurs after minimal trauma. When hemarthrosis following minimal trauma is not due to a bleeding diathesis, the most commonly documented injuries are anterior cruciate ligament (ACL), meniscal tears, and patellar subluxations. (See <a class="local">'Lipohemarthrosis'</a> above and <a class="local">'Minimal injuries'</a> above and <a class="local">'Postoperative'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A variety of hereditary, acquired, and iatrogenic bleeding disorders can result in hemarthrosis. Bleeding disorders should be considered when hemarthrosis occurs with minimal or no recollected trauma. Hemarthrosis is typically seen with deficiencies in coagulation factors, rather than platelets  (<a class="graphic graphic_table graphicRef77834" href="/z/d/graphic/77834.html" rel="external">table 4</a>). Three forms of hemarthrosis due to hemophilia and other coagulopathies are recognized: acute, subacute, and chronic; and five stages of hemophilic arthropathy have been identified. (See <a class="local">'Bleeding disorders'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Potential causes of hemarthrosis other than bleeding disorders and trauma include neurologic, infectious, and vascular disorders; inflammatory, degenerative, and crystalline arthritis; and neoplasms, including tenosynovial giant cell tumor (formerly termed pigmented villonodular synovitis). (See <a class="local">'Nontraumatic'</a> above and <a class="local">'Osteoarthritis'</a> above and <a class="local">'Neurologic disorders'</a> above and <a class="local">'Septic arthritis'</a> above and <a class="local">'Vascular disorders'</a> above and <a class="local">'Tumors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The treatment of hemarthrosis includes interventions that are generally useful for any patient with an acute hemarthrosis and more specific treatments directed toward the underlying disorder. Treatments of general benefit include immobilization, ice, and compression initially; analgesia; and arthrocentesis. Lavage is generally not required but can be considered (together with glucocorticoid instillation) for recurrent hemarthrosis associated with hemophilia. Nonsteroidal antiinflammatory drugs (NSAIDs) that interfere with platelet function should be avoided, and thus the use of cyclooxygenase (COX) 2 inhibitors is encouraged. Specific treatment can be employed when a definite cause for the hemarthrosis can be identified. (See <a class="local">'General approach'</a> above and <a class="local">'Cause-specific interventions'</a> above and <a class="local">'After major trauma'</a> above and <a class="local">'Postoperative'</a> above and <a class="local">'Vascular causes'</a> above and <a class="local">'Benign tumors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The approach to patients treated with anticoagulation is variable, depending upon the risk of reduced anticoagulation therapy. The treatment of patients with known clotting factor deficiency is described in detail separately. (See <a class="local">'Coagulation disorders/hemophilia'</a> above and  <a class="medical medical_review" href="/z/d/html/1314.html" rel="external">"Treatment of bleeding and perioperative management in hemophilia A and B"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Baker CL. Acute hemarthrosis of the knee. J Med Assoc Ga 1992; 81:301.</a></li><li><a class="nounderline abstract_t">Maffulli N, Binfield PM, King JB, Good CJ. Acute haemarthrosis of the knee in athletes. A prospective study of 106 cases. J Bone Joint Surg Br 1993; 75:945.</a></li><li><a class="nounderline abstract_t">Visuri T, Koskenvuo M, Dahlström S. Hemarthrosis of the clinically stable knee due to sports and military training in young recruits: an arthroscopic analysis. Mil Med 1993; 158:378.</a></li><li><a class="nounderline abstract_t">Askenberger M, Ekström W, Finnbogason T, Janarv PM. Occult Intra-articular Knee Injuries in Children With Hemarthrosis. Am J Sports Med 2014; 42:1600.</a></li><li><a class="nounderline abstract_t">Allum R. The management of acute traumatic haemarthrosis of the knee. Br J Hosp Med 1997; 58:138.</a></li><li><a class="nounderline abstract_t">Bomberg BC, McGinty JB. Acute hemarthrosis of the knee: indications for diagnostic arthroscopy. Arthroscopy 1990; 6:221.</a></li><li><a class="nounderline abstract_t">Ryu KN, Jaovisidha S, De Maeseneer M, et al. Evolving stages of lipohemarthrosis of the knee. Sequential magnetic resonance imaging findings in cadavers with clinical correlation. Invest Radiol 1997; 32:7.</a></li><li><a class="nounderline abstract_t">Lugo-Olivieri CH, Scott WW Jr, Zerhouni EA. Fluid-fluid levels in injured knees: do they always represent lipohemarthrosis? Radiology 1996; 198:499.</a></li><li><a class="nounderline abstract_t">Bianchi S, Zwass A, Abdelwahab IF, et al. Sonographic evaluation of lipohemarthrosis: clinical and in vitro study. J Ultrasound Med 1995; 14:279.</a></li><li><a class="nounderline abstract_t">Ames PR, Maffulli N, Capasso G, Brancaccio V. Minimal trauma knee hemarthrosis. Bull Hosp Jt Dis 1996; 54:258.</a></li><li><a class="nounderline abstract_t">Lu KH, Hsiao YM, Lin ZI. Arthroscopy for acute knee haemarthrosis in road traffic accident victims. Injury 1996; 27:341.</a></li><li><a class="nounderline abstract_t">Saksena J, Platts AD, Dowd GS. Recurrent haemarthrosis following total knee replacement. Knee 2010; 17:7.</a></li><li><a class="nounderline abstract_t">Worland RL, Jessup DE. Recurrent hemarthrosis after total knee arthroplasty. J Arthroplasty 1996; 11:977.</a></li><li><a class="nounderline abstract_t">Ballard WT, Clark CR, Callaghan JJ. Recurrent spontaneous hemarthrosis nine years after a total knee arthroplasty. A presentation with pigmented villonodular synovitis. J Bone Joint Surg Am 1993; 75:764.</a></li><li><a class="nounderline abstract_t">Oishi CS, Elliott ML, Colwell CW Jr. Recurrent hemarthrosis following a total knee arthroplasty. J Arthroplasty 1995; 10 Suppl:S56.</a></li><li><a class="nounderline abstract_t">Schneider T, Fink B, Abel R, et al. Hemarthrosis as a major complication after arthroscopic subcutaneous lateral retinacular release: a prospective study. Am J Knee Surg 1998; 11:95.</a></li><li><a class="nounderline abstract_t">Wild JH, Zvaifler NJ. Hemarthrosis associated with sodium warfarin therapy. Arthritis Rheum 1976; 19:98.</a></li><li><a class="nounderline abstract_t">Jaffer AM, Schmid FR. Hemarthrosis associated with sodium warfarin. J Rheumatol 1977; 4:215.</a></li><li><a class="nounderline abstract_t">Birnbaum Y, Stahl B, Rechavia E. Spontaneous hemarthrosis following thrombolytic therapy for acute myocardial infarction. Int J Cardiol 1993; 40:289.</a></li><li><a class="nounderline abstract_t">Finlayson J, Dunsmuir RA. Haemarthrosis following thrombolytic therapy for acute myocardial infarction. Injury 1997; 28:146.</a></li><li><a class="nounderline abstract_t">Lan HH, Eustace SJ, Dorfman D. Hemophilic arthropathy. Radiol Clin North Am 1996; 34:446.</a></li><li><a class="nounderline abstract_t">Blanchette VS, Key NS, Ljung LR, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 2014; 12:1935.</a></li><li><a class="nounderline abstract_t">Soucie JM, Cianfrini C, Janco RL, et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 2004; 103:2467.</a></li><li><a class="nounderline abstract_t">Arnold WD, Hilgartner MW. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977; 59:287.</a></li><li><a class="nounderline abstract_t">van Vulpen LFD, Holstein K, Martinoli C. Joint disease in haemophilia: Pathophysiology, pain and imaging. Haemophilia 2018; 24 Suppl 6:44.</a></li><li><a class="nounderline abstract_t">Roosendaal G, Vianen ME, Marx JJ, et al. Blood-induced joint damage: a human in vitro study. Arthritis Rheum 1999; 42:1025.</a></li><li><a class="nounderline abstract_t">Rodriguez-Merchan EC. The destructive capabilities of the synovium in the haemophilic joint. Haemophilia 1998; 4:506.</a></li><li><a class="nounderline abstract_t">Roosendaal G, Tekoppele JM, Vianen ME, et al. Articular cartilage is more susceptible to blood induced damage at young than at old age. J Rheumatol 2000; 27:1740.</a></li><li><a class="nounderline abstract_t">Wen FQ, Jabbar AA, Chen YX, et al. c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. Blood 2002; 100:912.</a></li><li><a class="nounderline abstract_t">Jansen NW, Roosendaal G, Bijlsma JW, et al. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis Rheum 2007; 56:199.</a></li><li><a class="nounderline abstract_t">Christensen KR, Kjelgaard-Hansen M, Nielsen LN, et al. Rapid inflammation and early degeneration of bone and cartilage revealed in a time-course study of induced haemarthrosis in haemophilic rats. Rheumatology (Oxford) 2019; 58:588.</a></li><li><a class="nounderline abstract_t">Sun J, Hua B, Livingston EW, et al. Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis. Blood 2017; 129:2161.</a></li><li><a class="nounderline abstract_t">Bhat V, Olmer M, Joshi S, et al. Vascular remodeling underlies rebleeding in hemophilic arthropathy. Am J Hematol 2015; 90:1027.</a></li><li><a class="nounderline abstract_t">Feldman BM. Preventing joint damage from hemophilia. J Rheumatol 2000; 27:1579.</a></li><li><a class="nounderline abstract_t">Kawamura H, Ogata K, Miura H, et al. Spontaneous hemarthrosis of the knee in the elderly: etiology and treatment. Arthroscopy 1994; 10:171.</a></li><li><a class="nounderline abstract_t">Dougados M. Synovial fluid cell analysis. Baillieres Clin Rheumatol 1996; 10:519.</a></li><li><a class="nounderline abstract_t">Mowad CM, Howe KL, Guzzo CA. Unexplained hemothorax, hemarthrosis, and palpable purpura. Hosp Pract (Off Ed) 1995; 30:55.</a></li><li><a class="nounderline abstract_t">Klein GE, Raith J, Passler J, et al. Spontaneous recurrent hemarthrosis of the knee joint: endovascular treatment of a ruptured aneurysm with platinum microcoils. A case report. J Bone Joint Surg Am 1997; 79:594.</a></li><li><a class="nounderline abstract_t">Wirth T, Rauch G, Rüschoff J, Griss P. Synovial haemangioma of the knee joint. Int Orthop 1992; 16:130.</a></li><li><a class="nounderline abstract_t">Frick MA, Wenger DE, Adkins M. MR imaging of synovial disorders of the knee: an update. Radiol Clin North Am 2007; 45:1017.</a></li><li><a class="nounderline abstract_t">Larbi A, Viala P, Cyteval C, et al. Imaging of tumors and tumor-like lesions of the knee. Diagn Interv Imaging 2016; 97:767.</a></li><li><a class="nounderline abstract_t">West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A 2006; 103:690.</a></li><li><a class="nounderline abstract_t">Frassica FJ, Bhimani MA, McCarthy EF, Wenz J. Pigmented villonodular synovitis of the hip and knee. Am Fam Physician 1999; 60:1404.</a></li><li><a class="nounderline abstract_t">Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 2011; 70:571.</a></li><li><a class="nounderline abstract_t">Sierra Aisa C, Lucía Cuesta JF, Rubio Martínez A, et al. Comparison of ultrasound and magnetic resonance imaging for diagnosis and follow-up of joint lesions in patients with haemophilia. Haemophilia 2014; 20:e51.</a></li><li><a class="nounderline abstract_t">Hanley J, McKernan A, Creagh MD, et al. Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline. Haemophilia 2017; 23:511.</a></li><li><a class="nounderline abstract_t">Simpson ML, Valentino LA. Management of joint bleeding in hemophilia. Expert Rev Hematol 2012; 5:459.</a></li><li><a class="nounderline abstract_t">Gualtierotti R, Tafuri F, Arcudi S, et al. Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy. Pain Ther 2022; 11:1.</a></li><li><a class="nounderline abstract_t">Manners PJ, Price P, Buurman D, et al. Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data. J Rheumatol 2015; 42:885.</a></li><li><a class="nounderline abstract_t">Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia 2006; 12:514.</a></li><li><a class="nounderline abstract_t">Tsoukas C, Eyster ME, Shingo S, et al. Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy. Blood 2006; 107:1785.</a></li><li><a class="nounderline abstract_t">Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016; 375:2519.</a></li><li><a class="nounderline abstract_t">Melchiorre D, Morfini M, Linari S, et al. Anti-TNF-α therapy prevents the recurrence of joint bleeding in haemophilia and arthritis. Rheumatology (Oxford) 2014; 53:576.</a></li><li><a class="nounderline abstract_t">Haxaire C, Hakobyan N, Pannellini T, et al. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway. Blood 2018; 132:1064.</a></li><li><a class="nounderline abstract_t">Zhang F, Xu M, Yang Q, et al. A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy. J Clin Med 2019; 9.</a></li><li><a class="nounderline abstract_t">Thumboo J, O'Duffy JD. A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium. Arthritis Rheum 1998; 41:736.</a></li><li><a class="nounderline abstract_t">Son KM, Kim JK, Seo YI, Kim HA. A case of bilateral hemarthrosis due to pseudoaneurysms in a patient on anticoagulation therapy. J Clin Rheumatol 2013; 19:206.</a></li><li><a class="nounderline abstract_t">Katsimihas M, Robinson D, Thornton M, Langkamer VG. Therapeutic embolization of the genicular arteries for recurrent hemarthrosis after total knee arthroplasty. J Arthroplasty 2001; 16:935.</a></li><li><a class="nounderline abstract_t">Omary R, Stulberg SD, Vogelzang RL. Therapeutic embolization of false aneurysms of the superior medial genicular artery after operations on the knee. A report of two cases. J Bone Joint Surg Am 1991; 73:1257.</a></li><li><a class="nounderline abstract_t">Wyseure T, Mosnier LO, von Drygalski A. Advances and challenges in hemophilic arthropathy. Semin Hematol 2016; 53:10.</a></li><li><a class="nounderline abstract_t">Goren R, Pullenayegum E, Blanchette VS, et al. Patterns of joint damage in severe haemophilia A treated with prophylaxis. Haemophilia 2021; 27:666.</a></li><li><a class="nounderline abstract_t">Stimec J, Dover S, Pullenayegum E, et al. Magnetic resonance imaging in boys with severe hemophilia A: Serial and end-of-study findings from the Canadian Hemophilia Primary Prophylaxis Study. Res Pract Thromb Haemost 2021; 5:e12565.</a></li></ol></div><div id="topicVersionRevision">Topic 5605 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1607844" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute hemarthrosis of the knee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8245089" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Acute haemarthrosis of the knee in athletes. A prospective study of 106 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8361594" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hemarthrosis of the clinically stable knee due to sports and military training in young recruits: an arthroscopic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24753236" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Occult Intra-articular Knee Injuries in Children With Hemarthrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9373401" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The management of acute traumatic haemarthrosis of the knee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2206185" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Acute hemarthrosis of the knee: indications for diagnostic arthroscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9007642" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Evolving stages of lipohemarthrosis of the knee. Sequential magnetic resonance imaging findings in cadavers with clinical correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8596856" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Fluid-fluid levels in injured knees: do they always represent lipohemarthrosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7602685" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Sonographic evaluation of lipohemarthrosis: clinical and in vitro study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8731422" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Minimal trauma knee hemarthrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8763289" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Arthroscopy for acute knee haemarthrosis in road traffic accident victims.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19616438" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Recurrent haemarthrosis following total knee replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8986579" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Recurrent hemarthrosis after total knee arthroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8501094" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Recurrent spontaneous hemarthrosis nine years after a total knee arthroplasty. A presentation with pigmented villonodular synovitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8776057" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Recurrent hemarthrosis following a total knee arthroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9586738" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hemarthrosis as a major complication after arthroscopic subcutaneous lateral retinacular release: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1252272" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Hemarthrosis associated with sodium warfarin therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/881700" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hemarthrosis associated with sodium warfarin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8225665" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Spontaneous hemarthrosis following thrombolytic therapy for acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9205584" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Haemarthrosis following thrombolytic therapy for acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8633126" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hemophilic arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25059285" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Definitions in hemophilia: communication from the SSC of the ISTH.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14615381" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/849938" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Hemophilic arthropathy. Current concepts of pathogenesis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29878659" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Joint disease in haemophilia: Pathophysiology, pain and imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10323460" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Blood-induced joint damage: a human in vitro study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9873783" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The destructive capabilities of the synovium in the haemophilic joint.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10914861" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Articular cartilage is more susceptible to blood induced damage at young than at old age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12130502" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17195222" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29982826" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Rapid inflammation and early degeneration of bone and cartilage revealed in a time-course study of induced haemarthrosis in haemophilic rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28039188" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26257191" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Vascular remodeling underlies rebleeding in hemophilic arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10914833" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Preventing joint damage from hemophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8003144" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Spontaneous hemarthrosis of the knee in the elderly: etiology and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8876957" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Synovial fluid cell analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7883809" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Unexplained hemothorax, hemarthrosis, and palpable purpura.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9111408" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Spontaneous recurrent hemarthrosis of the knee joint: endovascular treatment of a ruptured aneurysm with platinum microcoils. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1428309" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Synovial haemangioma of the knee joint.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17981181" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : MR imaging of synovial disorders of the knee: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27397886" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Imaging of tumors and tumor-like lesions of the knee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16407111" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10524485" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Pigmented villonodular synovitis of the hip and knee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21257614" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : EULAR recommendations for calcium pyrophosphate deposition. Part II: management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24112687" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Comparison of ultrasound and magnetic resonance imaging for diagnosis and follow-up of joint lesions in patients with haemophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28370924" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22992238" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Management of joint bleeding in hemophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35020184" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25729030" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16919082" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16291600" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27959716" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24136067" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Anti-TNF-αtherapy prevents the recurrence of joint bleeding in haemophilia and arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29776906" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-αpathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31892201" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9550485" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23669803" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A case of bilateral hemarthrosis due to pseudoaneurysms in a patient on anticoagulation therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11607913" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Therapeutic embolization of the genicular arteries for recurrent hemarthrosis after total knee arthroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1890130" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Therapeutic embolization of false aneurysms of the superior medial genicular artery after operations on the knee. A report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26805902" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Advances and challenges in hemophilic arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34015166" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Patterns of joint damage in severe haemophilia A treated with prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34703973" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Magnetic resonance imaging in boys with severe hemophilia A: Serial and end-of-study findings from the Canadian Hemophilia Primary Prophylaxis Study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
